ArticlemedRxiv : the preprint server for health sciences2021

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study.

Naomi J Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.